Trial intelligence / Profile preview

Adrenal Cortical Function and Vitamin A Deficiency in Sepsis

NCT03152474Phase 4Completed

Sponsor
The Lundquist Institute
Start
Feb 1993
Primary completion
Jan 2000
Modality
Orthosteric Ligands
01

Overview

Phase 4, randomised, double-blind trial of methylprednisolone injection and vitamin a in sepsis and septic shock (3 arms), sponsored by The Lundquist Institute. Primary endpoint: 28 days mortality. Started Feb 1993; status: completed.

02

Drugs

methylprednisolone injectionvitamin a
03

Conditions

sepsisseptic shock

Beyond the preview

Go deeper on NCT03152474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03152474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call